Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Huarong Pharmaceutical is a specialized subsidiary of the CSPC Pharmaceutical Group, based in Shijiazhuang, China. The company is a major manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), with a core focus on the production of cephalosporin antibiotics. Its primary product is 7-aminocephalosporanic acid (7-ACA), which serves as the essential core intermediate for the synthesis of various semi-synthetic cephalosporins. Hebei Huarong operates large-scale fermentation and chemical synthesis facilities that support the global supply chain for anti-infective medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Huarong.